期刊文献+

雅培i1000SR全自动化学发光分析仪检测DHEA-S和SHBG的性能验证 被引量:3

Performance verification of ARCHITECT i1000SR automatic chemiluminescence analyzer for detecting DHEA-S and SHBG
下载PDF
导出
摘要 目的验证评价雅培i1000SR全自动化学发光分析仪使用化学发光微粒子免疫分析法检测硫酸脱氢表雄酮(dehydroepiandrosterone sulfate,DHEA-S)、性激素结合球蛋白(sex hormone-binding globulin,SHBG)的性能。方法根据ISO15189《医学实验室质量和能力认可准则》要求,同时参照美国临床实验室标准协会CLSI EP系列文件以及相关标准,本研究使用雅培i1000SR于2020年3月对各质控品和临床样本进行DHEA-S、SHBG的非随机对照实验性研究,对DHEA-S、SHBG进行精密度、正确度以及线性范围验证,最后将验证结果与厂家声称性能指标进行相比。结果DHEA-S浓度水平1和水平2验证的批内CV、总CV分别为1.20%、3.68%和1.48%、1.70%,SHBG浓度水平1和水平2验证的批内CV、总CV分别为4.00%、0.80%和4.94%、2.03%,二者均小于厂家声明的6.25%的批内CV和8.33%的总CV,精密度验证通过。DHEA-S的5份质控品其验证偏差结果分别为-7.0%、-6.8%、-4.8%、4.7%和-2.5%,SHBG的5份质控品其验证偏差结果分别为-4.5%、-3.7%、-1.4%、-2.5%和-2.1%,结果均小于±12.5%,即总允许误差(TEa)的1/2,正确度符合实验室要求;DHEA-S、SHBG验证的线性范围是5.10~1301.07μg/dL和1.90~221.13 nmol/L,均在厂家线性范围内,二者具有良好的线性关系(DHEA-S的R2=0.9993,SHBG的R2=0.9966,相关系数R2>0.95);测定结果准确可靠,精密度较高,准确度较高,线性范围宽,以上性能指标均符合厂家声称的性能要求。结论雅培i1000SR全自动化学发光分析仪检测DHEA-S、SHBG的性能验证的结果均符合临床的要求,可用于大批量临床标本的检测,DHEA-S、SHBG对性激素相关疾病的诊断具有重要价值。 Objective To verify and evaluate the methodological performance of chemiluminescence microparticle immunoassay in the ARCHITECT i1000SR automatic chemiluminescence analyzer for detecting dehydroepiandrosterone sulfate(DHEA-S)and sex hormone-binding globulin(SHBG).Methods According to the requirements of the Accreditation Criteria for the Quality and Competence of Medical Laboratories(ISO15189),as well as referring to EP series documents of CLSI and related standards,in March 2020,ARCHITECT i1000SR was used to to measure the trial results of DHEA-S and SHBG in each quality control product and clinical sample to verify their precisions,accuracies,and line ranges,and were compared with the manufacturer's stated performance indicators.Results The within-run CV and total CV of DHEA-S were 1.20%and 3.68%on level 1,and were 1.48%and 1.70%on level 2;the within-run CV and total CV of SHBG were 4.00%and 0.80%on level 1,and were 4.94%and 2.03%on level 2;which were all smaller than those of the inter-laboratory quality assessment standards——6.25%and 8.33%;it suggested that the manufacturer's claims were verifiable.The deviations of DHEA-S'5 controls were-7.0%,-6.8%,-4.8%,4.7%,and-2.5%,and those of SHBG's were-4.5%,-3.7%,-1.4%,-2.5%,and-2.1%,which were all smaller than±12.5%,1/2 TEa,and met the laboratory declaration requirements.The validation line arrange of DHEA-S was 5.10-1301.07μg/dL,and that of SHBG 1.90-221.13 nmol,and both were within the manufacturer's range,showing a good linearity relation(DHEA-S:R2=0.9993;SHBG:R2=0.9966;correlation coefficient R2>0.95).The detection results were accurate and reliable,with high precision,high accuracy,and wide line range.All the above performance indicators met the manufacturer's requirements.Conclusion The performance verification results of the ARCHITECT i1000SR automatic chemiluminescence analyzer for the detection of DHEA-S and SHBG meet the clinical requirements,and can be used for the detection of large quantities of clinical specimens.DHEA-S and SHBG have important value in the diagnosis of sex hormone related diseases.
作者 林城通 石文 陈林 黄爱军 林海标 Lin Chengtong;Shi Wen;Chen Lin;Huang Aijun;Lin Haibiao(Medical Laboratory,Traditional Chinese Medicine Hospital of Guangdong Province,Guangzhou 510000,China)
出处 《国际医药卫生导报》 2021年第15期2269-2273,共5页 International Medicine and Health Guidance News
基金 广东省医学科学技术研究基金项目(A2021137)。
关键词 性能验证 雅培i1000SR 硫酸脱氢表雄酮 性激素结合球蛋白 Performance verification ARCHITECT i1000SR Dehydroepiandrosterone sulfate Sex hormone-binding globulin
  • 相关文献

参考文献7

二级参考文献45

  • 1陈文祥,申子瑜,杨振华.临床检验分析质量指标的设定[J].中华检验医学杂志,2006,29(4):298-300. 被引量:51
  • 2张秀明,郑松柏,孙蕾,柯培锋,马骥,张文,林莲英.应用Westgard方法评价决定图判断生化检测系统性能的可接受性[J].中华检验医学杂志,2007,30(1):86-90. 被引量:73
  • 3张秀明,黄宪章,曾方银,等.临床生化检验诊断学[M].北京:人民卫生出版社,2012:867-870.
  • 4WS/T403-2012.临床生物化学检验常规项目分析质量指标.中华人民共和国卫生部,2012.
  • 5中国合格评审国家认可委员会.医学实验室质量和能力认可准则(ISO15189:2012,IDT)[s].2013.
  • 6CLSI EP15-A3. User verification of precision and estimation of bias; Approved guideline-Third edition[ S]. CLSI,2014.
  • 7CLSI EP15-A2. User verification of performance for precision and trueness; Approved guideline-Second edition[ S]. CLSI,2005.
  • 8CLSI EP15-A. User demonstration of performance for precision and accuracy ; Approved guideline [ S ]. CLSI,2001.
  • 9CLSI EP10-A3. Preliminary evaluation of quantitative clinical labora- tory measurement procedures ; Approved guideline-Third edition [ S ]. CLS1,2006.
  • 10CLSI EP5-A3. Evaluation of precision of quantitative procedures ; Approved guideline-Third edition[ S 1. CLS1,2014.

共引文献90

同被引文献43

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部